Adv Biomed Res. 2015 May 11;4:93. doi: 10.4103/2277-9175.156657. eCollection 2015.
The effect of time and temperature on viability and performance of Langerhans islets separated from Balb/c mouse after death.
Advanced biomedical research
Rostam Ghorbani, Cyrus Jalili, Mohammad Reza Salahshoor, Maryam Shiasi
Affiliations
Affiliations
- Fertility and Infertility Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran.
- Department of Anatomy, Tehran University of Medical Sciences, Tehran, Iran.
PMID: 26015919
PMCID: PMC4434490 DOI: 10.4103/2277-9175.156657
Abstract
BACKGROUND: Tissue transplantation plays a pivotal role in the treatment of diseases. Pancreatic beta cell transplantation is the best way to obtain normal blood glucose in patients with diabetes type 1. However, it is not clear how long endocrine pancreas cells can be used for transplantation after the donor's death. The present study was conducted to analyze the performance and viability of pancreatic islet cells after death.
MATERIALS AND METHODS: Pancreas was separated from Balb/c mice at different times (0, 1, 4, 6, 12, and 24 h after death) at temperatures of 4°C and 23°C, and was cultured in Roswell_Park_Memorial_Institute (RPMI) 1640. Insulin shock, MTT assay, aldehyde fuchsin staining, dithizone staining, and florescence microscopy methods were applied to analyze the performance of beta cells, cell viability, islets' diagnosis, islet cells' diagnosis, and viable and necrotic cells diagnosis, respectively.
RESULTS: Islets of Langerhans and beta cells were diagnosed. By increasing the temperature and time, the viability and performance of beta cells decreased significantly (P < 0.05).
CONCLUSION: The best condition for keeping the islets of Langerhans in terms of viability and performance is 4 h after death at temperature of 4°C.
Keywords: Cell viability; Langerhans islets; performance; temperature; time
References
- Diabetes. 2003 Dec;52(12):2935-42 - PubMed
- Diabetes. 2013 May;62(5):1646-55 - PubMed
- Toxicol Pathol. 2014 Jan;42(1):45-8 - PubMed
- Pancreas. 2013 Mar;42(2):317-21 - PubMed
- BMC Complement Altern Med. 2013 Aug 19;13:212 - PubMed
- Res Pharm Sci. 2014 Sep-Oct;9(5):351-8 - PubMed
- J Mol Endocrinol. 1996 Feb;16(1):1-8 - PubMed
- Liver Transpl. 2013 Mar;19(3):328-35 - PubMed
- Gastrointest Endosc. 2013 May;77(5):784-92 - PubMed
- Transplantation. 2011 Mar 15;91(5):508-14 - PubMed
- Ann Surg. 2003 Jun;237(6):741-9; discussion 749-50 - PubMed
- Leg Med (Tokyo). 2004 Mar;6(1):25-31 - PubMed
- Diabetologia. 2013 Mar;56(3):508-19 - PubMed
- Cardiovasc Intervent Radiol. 1999 Jul-Aug;22(4):342-4 - PubMed
- Cell Transplant. 2013;22(7):1101-11 - PubMed
- Diabetes. 1967 Jan;16(1):35-9 - PubMed
- Cell Mol Biol Lett. 2011 Mar;16(1):101-13 - PubMed
- Transplant Proc. 2001 Feb-Mar;33(1-2):1707-8 - PubMed
- Diabetologia. 1976 May;12(2):115-21 - PubMed
- J Assoc Res Otolaryngol. 2007 Jun;8(2):194-204 - PubMed
- J Clin Endocrinol Metab. 2013 Apr;98(4):E727-31 - PubMed
- Physiol Res. 2004;53(3):327-33 - PubMed
- Islets. 2013 May-Jun;5(3):111-5 - PubMed
- Am J Physiol. 1982 May;242(5):C382-7 - PubMed
- Ann Surg. 2000 Feb;231(2):269-75 - PubMed
- World J Gastroenterol. 2009 Sep 7;15(33):4163-9 - PubMed
- Cytotechnology. 2005 Jun;48(1-3):75-8 - PubMed
- Fitoterapia. 2013 Jun;87:84-8 - PubMed
- Biosci Biotechnol Biochem. 2003 Nov;67(11):2396-401 - PubMed
Publication Types